Spinal Cord Stimulator Lawsuit Stays in Illinois
Illinois patients with implanted Medtronic neurostimulators have a suit over injuries kept in their home state.
Updated on Nov. 5, 2026 in Stroke
A federal judge in Illinois denied Medtronic's request to move a spinal cord stimulator injury lawsuit to Minnesota, keeping the case in the state where the device was implanted. The order was issued October 26 and concerns a patient implanted with the device to treat chronic neck and back pain.
Why it matters
The ruling determines where a product-liability case over a neurostimulator will be heard, which affects how quickly patients who allege device injuries can reach a decision. The court concluded the case has a stronger connection to Illinois, where the device was implanted and the alleged injuries occurred.
The ruling is a procedural decision by U.S. District Judge Jonathan Hawley, not a finding on whether the device caused injury. It rests on the location of the implant and the alleged injuries, with Medtronic bearing the burden of showing transfer was warranted.
The players
Medtronic
Medtronic is a major medical technology company known for implantable neurostimulators, including spinal cord stimulators used for chronic pain.
U.S. District Court for the Central District of Illinois
This federal court handles civil litigation in central Illinois and issued the venue ruling in the case.
The details
Steven Hughes, an Illinois resident, was implanted with the Medtronic Intellis LT rechargeable neurostimulator in March 2022 to treat chronic neck and back pain. Medtronic asked the court to move the case to the District of Minnesota, but the judge found the dispute has greater ties to Illinois. Venue rules weigh where the events occurred, which here means where the device was placed in the patient.
Timeline
March 2022: Steven Hughes is implanted with the Medtronic neurostimulator.
October 26, 2026: Judge Hawley denies Medtronic's motion to transfer the case.
Health Landscape
Spinal cord stimulators are an established option for chronic back and neck pain, and litigation over implanted devices is part of how their safety record is tested. Venue decisions like this one shape where such device claims are resolved across the country.
If you have a spinal cord stimulator and have concerns about its performance, bring them to your prescribing physician or the implanting team. Anyone considering this treatment for chronic back or neck pain should discuss the device's known risks and benefits with their doctor before deciding.
The takeaway
Court venue rulings determine where device injury cases are heard, and this one keeps the dispute in Illinois, where the implant occurred. For personal questions about a neurostimulator, your physician is the right first contact.
Further reading
For related coverage of neurological conditions, browse our Stroke section.
Source note: This article includes information reported by Harrismartin.
